258 related articles for article (PubMed ID: 20232266)
21. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
22. Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking.
Diop M; Auberval N; Viciglio A; Langlois A; Bietiger W; Mura C; Peronet C; Bekel A; Julien David D; Zhao M; Pinget M; Jeandidier N; Vauthier C; Marchioni E; Frere Y; Sigrist S
Int J Pharm; 2015 Aug; 491(1-2):402-8. PubMed ID: 26049075
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C
J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366
[TBL] [Abstract][Full Text] [Related]
24. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
26. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
27. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
28. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
Bal SM; Slütter B; van Riet E; Kruithof AC; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
J Control Release; 2010 Mar; 142(3):374-83. PubMed ID: 19932723
[TBL] [Abstract][Full Text] [Related]
29. Effects of degree of quaternization on the preparation and characterization of insulin-loaded trimethyl chitosan polyelectrolyte complexes optimized by central composite design.
Jin Y; Zhou D; Yang HY; Zhu X; Wang XR; Zhang ZR; Huang Y
Pharm Dev Technol; 2012; 17(6):719-29. PubMed ID: 21563989
[TBL] [Abstract][Full Text] [Related]
30. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins.
Sonaje K; Lin KJ; Tseng MT; Wey SP; Su FY; Chuang EY; Hsu CW; Chen CT; Sung HW
Biomaterials; 2011 Nov; 32(33):8712-21. PubMed ID: 21862121
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
Chen F; Zhang ZR; Yuan F; Qin X; Wang M; Huang Y
Int J Pharm; 2008 Feb; 349(1-2):226-33. PubMed ID: 17825506
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
33. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
du Plessis LH; Kotzé AF; Junginger HE
Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
[TBL] [Abstract][Full Text] [Related]
34. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
35. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
36. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats.
Wang XQ; Dai JD; Zhang H; Zhang X; Wang JC; Zhang Q
J Nanosci Nanotechnol; 2008 May; 8(5):2422-31. PubMed ID: 18572658
[TBL] [Abstract][Full Text] [Related]
37. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.
Zhang P; Xu Y; Zhu X; Huang Y
Int J Pharm; 2015 Dec; 496(2):993-1005. PubMed ID: 26541299
[TBL] [Abstract][Full Text] [Related]
38. Receptor mediated gene delivery by folate conjugated N-trimethyl chitosan in vitro.
Zheng Y; Cai Z; Song X; Yu B; Bi Y; Chen Q; Zhao D; Xu J; Hou S
Int J Pharm; 2009 Dec; 382(1-2):262-9. PubMed ID: 19686829
[TBL] [Abstract][Full Text] [Related]
39. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
40. Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum.
Sandri G; Rossi S; Ferrari F; Bonferoni MC; Zerrouk N; Caramella C
J Pharm Pharmacol; 2004 Sep; 56(9):1083-90. PubMed ID: 15324476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
